Glycaemic efficacy and safety of linagliptin compared to a basal‐bolus insulin regimen in patients with type 2 diabetes undergoing non‐cardiac surgery: A multicentre randomized clinical trial-Reference-Cited by-同舟云学术

Glycaemic efficacy and safety of linagliptin compared to a basal‐bolus insulin regimen in patients with type 2 diabetes undergoing non‐cardiac surgery: A multicentre randomized clinical trial

Published:2019-04 Issue:4 Volume:21 Page:837-843
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Vellanki Priyathama¹,Rasouli Neda²,Baldwin David³,Alexanian Sara⁴,Anzola Isabel¹,Urrutia Maria¹,Cardona Saumeth¹,Peng Limin⁵,Pasquel Francisco J.¹,Umpierrez Guillermo E.¹^ORCID,Bakhtiari Hoda⁶,Wang Cecilia Low⁶,Jones Jocelyn⁷,Modzelewski Katherine⁸,Ensminger Elizabeth⁸,Haw J. Sonya⁹,Fayfman Maya⁹,Ramos Clementina⁹,Gomez Patricia⁹, ,

Affiliation:

1. Division of Endocrinology, Metabolism and Lipids, Department of MedicineEmory University School of Medicine Atlanta Georgia

2. Division of Endocrinology, Metabolism and DiabetesDepartment of Medicine, University of Colorado‐Denver Denver Colorado

3. Division of EndocrinologyDepartment of Medicine, Rush University Medical Center Chicago Illinois

4. Division of Endocrinology, Diabetes and NutritionDepartment of Medicine, Boston University Boston Massachusetts

5. Department of Biostatistics, Rollins School of Public HealthEmory University Atlanta Georgia

6. University of Colorado, Division of Endocrinology

7. Rush University, Division of Endocrinology

8. Boston University, Division of Endocrinology

9. Emory University, Division of Endocrinology, Metabolism and Lipids

Funder

Boehringer Ingelheim

National Institutes of Health

National Center for Research Resources

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13587

Reference28 articles.

1. Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes

2. Glucose Control and Mortality in Critically Ill Patients

3. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*

4. Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients

5. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Would You Treat This Inpatient With Type 2 Diabetes Mellitus? Grand Rounds Discussion From Beth Israel Deaconess Medical Center;Annals of Internal Medicine;2024-08

2. Treatment of Diabetes in Hospitals With Noninsulin Medications Is a Research Priority;Diabetes Care;2024-05-20

3. Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial;Journal of Diabetes and its Complications;2024-05

4. Antidiabéticos Não Insulínicos na Abordagem da Hiperglicemia nos Doentes Hospitalizados por Doença Aguda Não Crítica;Acta Médica Portuguesa;2024-02-05

5. In‐Hospital Treatment and Surgery in People with Diabetes;Textbook of Diabetes;2024-01-12